Month: November 2024

ZaiLab_EN_logo_-XL-RGB

Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2024 National Reimbursement Drug List...

Recursive_KAIMRC_MoU_signing_202411

AI Startup, Recursive, Signs Memorandum of Understanding with Saudi Arabia’s Largest Medical Research Institution, King Abdullah International Medical Research Center, to Develop AI and Data Science Solution for Tackling Tuberculosis